What's The BUZZ?

Market News, Products, Services, and Trends

Low-Dose Aspirin: the ‘Heavy-Weight’ Champion for Primary Prevention in All Patients? – Pharmacists

Low-dose daily aspirin is ubiquitously prescribed in health practices and used over-the-counter by many patients. However, recent studies and expert guidance suggest that NOT everyone is a candidate and that low-dose, daily aspirin may cause more harm than benefit in certain instances. This application-based continuing pharmacy education course provides a ‘journal club format’ discussion for pharmacists and student pharmacists to review a recent study on the impact of bodyweight on aspirin dose. Join us to discuss the strengths, limitations, and implications of this work on primary care practice and when prescribing and de-prescribing aspirin may be appropriate.

CEI

CEI News & Announcements

We’re Your Partner for Life Long Learning. With more than 25 years in the CE business, we create education and training, partner on your education ideas, and license our learning management system. How can we serve you?

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Low-Dose Aspirin: the ‘Heavy-Weight’ Champion for Primary Prevention in All Patients? – Pharmacists

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe